Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Yicheng Ningxin Pharmaceutical R&D Co., Ltd. is a specialized pharmaceutical research organization based in Nanjing, China, and a subsidiary of the Nanjing Yicheng Pharmaceutical group. The company focuses on the development of high-end generic drugs and improved new chemical entities (Class 2 drugs), with a strong focus on small molecule synthesis and formulation. Its core competencies include process chemistry, analytical development, and regulatory support for IND and NDA filings in the Chinese market. Yicheng Ningxin is particularly active in the therapeutic areas of cardiovascular disease, oncology, and anti-infectives. The firm plays a significant role in the consistency evaluation of generic drugs, ensuring domestic products meet international quality standards. By leveraging integrated R&D capabilities, the company supports the technical requirements of the Chinese pharmaceutical industry from laboratory innovation to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Edcheng Ningxin Pharmaceutical Research and Development.